The use of synergistic combinations of antibiotics in patients with haematological diseases.
D000380:Agranulocytosis / Q000150:complications*; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D001770:Blood Bactericidal Activity; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000150:complications; D005839:Gentamicins / Q000009:adverse effects / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007008:Hypokalemia / Q000209:etiology; D007668:Kidney / Q000187:drug effects; D007938:Leukemia / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D051381:Rats; D013997:Time Factors
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000667:Ampicillin; D002228:Carbenicillin; D002512:Cephalothin